Kahr WH - Search Results

1

Platelet disorders in children: A diagnostic approach.

Israels SJ, Kahr WH, Blanchette VS, Luban NL, Rivard GE, Rand ML. Israels SJ, et al. Among authors: kahr wh. Pediatr Blood Cancer. 2011 Jun;56(6):975-83. doi: 10.1002/pbc.22988. Epub 2011 Feb 3. Pediatr Blood Cancer. 2011. PMID: 21294245 Review.

2

The Sec1-Munc18 protein VPS33B forms a uniquely bidirectional complex with VPS16B.

Liu RJY, Al-Molieh Y, Chen SZ, Drobac M, Urban D, Chen CH, Yao HHY, Geng RSQ, Li L, Pluthero FG, Benlekbir S, Rubinstein JL, Kahr WHA. Liu RJY, et al. Among authors: kahr wha. J Biol Chem. 2023 Jun;299(6):104718. doi: 10.1016/j.jbc.2023.104718. Epub 2023 Apr 14. J Biol Chem. 2023. PMID: 37062417 Free PMC article.

3

Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator.

Kahr WH, Zheng S, Sheth PM, Pai M, Cowie A, Bouchard M, Podor TJ, Rivard GE, Hayward CP. Kahr WH, et al. Blood. 2001 Jul 15;98(2):257-65. doi: 10.1182/blood.v98.2.257. Blood. 2001. PMID: 11435291 Free article.

4

Intracellular activation of the fibrinolytic cascade in the Quebec Platelet Disorder.

Sheth PM, Kahr WH, Haq MA, Veljkovic DK, Rivard GE, Hayward CP. Sheth PM, et al. Among authors: kahr wh. Thromb Haemost. 2003 Aug;90(2):293-8. doi: 10.1160/TH02-12-0323. Thromb Haemost. 2003. PMID: 12888877

5

Insights into abnormal hemostasis in the Quebec platelet disorder from analyses of clot lysis.

Diamandis M, Adam F, Kahr WH, Wang P, Chorneyko KA, Arsenault AL, Rivard GE, Hayward CP. Diamandis M, et al. Among authors: kahr wh. J Thromb Haemost. 2006 May;4(5):1086-94. doi: 10.1111/j.1538-7836.2006.01877.x. J Thromb Haemost. 2006. PMID: 16689763 Free article.

6

Megakaryocyte and platelet abnormalities in a patient with a W33C mutation in the conserved SH3-like domain of myosin heavy chain IIA.

Kahr WH, Savoia A, Pluthero FG, Li L, Christensen H, De Rocco D, Traivaree C, Butchart SE, Curtin J, Stollar EJ, Forman-Kay JD, Blanchette VS. Kahr WH, et al. Thromb Haemost. 2009 Dec;102(6):1241-50. doi: 10.1160/TH09-02-0119. Thromb Haemost. 2009. PMID: 19967157

7

Homozygosity mapping with SNP arrays confirms 3p21 as a recessive locus for gray platelet syndrome and narrows the interval significantly.

Fabbro S, Kahr WH, Hinckley J, Wang K, Moseley J, Ryu GY, Nixon B, White JG, Bair T, Schutte B, Di Paola J. Fabbro S, et al. Among authors: kahr wh. Blood. 2011 Mar 24;117(12):3430-4. doi: 10.1182/blood-2010-12-322990. Epub 2011 Jan 24. Blood. 2011. PMID: 21263149 Free PMC article.

8

Inherited platelet disorders: a clinical approach to diagnosis and management.

Cox K, Price V, Kahr WH. Cox K, et al. Among authors: kahr wh. Expert Rev Hematol. 2011 Aug;4(4):455-72. doi: 10.1586/ehm.11.41. Expert Rev Hematol. 2011. PMID: 21801136 Review.

9

Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet-mediated events during thrombus formation.

Rand ML, Wang H, Pluthero FG, Stafford AR, Ni R, Vaezzadeh N, Allison AC, Kahr WH, Weitz JI, Gross PL. Rand ML, et al. Among authors: kahr wh. J Thromb Haemost. 2012 Jun;10(6):1109-19. doi: 10.1111/j.1538-7836.2012.04716.x. J Thromb Haemost. 2012. PMID: 22463102 Free article.

10

The VPS33B-binding protein VPS16B is required in megakaryocyte and platelet α-granule biogenesis.

Urban D, Li L, Christensen H, Pluthero FG, Chen SZ, Puhacz M, Garg PM, Lanka KK, Cummings JJ, Kramer H, Wasmuth JD, Parkinson J, Kahr WH. Urban D, et al. Among authors: kahr wh. Blood. 2012 Dec 13;120(25):5032-40. doi: 10.1182/blood-2012-05-431205. Epub 2012 Sep 21. Blood. 2012. PMID: 23002115 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103 results

Search Page